Smith Scott E 4
4 · ProUroCare Medical Inc. · Filed Aug 11, 2010
Insider Transaction Report
Form 4
Smith Scott E
Director
Transactions
- Award
Options
2010-08-10+14,535→ 14,535 totalExercise: $1.72Exp: 2017-08-10→ Common stock $0.00001 par value (14,535 underlying)
Holdings
- 1,000
Stock Options
Exercise: $1.00Exp: 2015-08-12→ Common stock, $0.00001 par value (1,000 underlying) - 20,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (20,000 underlying) - 20,000
Warrants
Exercise: $1.30From: 2009-11-12Exp: 2012-11-12→ Common stock, $0.00001 par value (20,000 underlying) - 132,550
Common stock, $0.00001 par value
- 7,000
Warrants
Exercise: $0.70Exp: 2012-12-31→ Common Stock, $0.00001 par value (7,000 underlying) - 1,000
Stock Options
Exercise: $1.25Exp: 2016-08-11→ Common Stock, $0.00001 par value (1,000 underlying) - 30,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (30,000 underlying) - 10,000
Warrants
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (10,000 underlying) - 32,475
Warrants
Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (32,475 underlying) - 3,000
Stock Options
Exercise: $7.00Exp: 2013-05-30→ Common Stock, $0.00001 par value (3,000 underlying)
Footnotes (3)
- [F1]Currently exercisable.
- [F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
- [F3]Annual option award pursuant to the Issuer's compensation policy for Directors upon re-election to the Board of Directors at its annual shareholders' meeting. The seven-year options vest immediately, and the $1.72 exercise price was set at the average of the close bid and asked prices quoted for the Issuer's common stock on the date of the annual meeting.